'Meat and Greet' fair brings farmers to local tables

The inaugural Meat and Greet Farmer and Chef Fair held March 11 at Hobart and William Smith Colleges in Geneva, New York, sought to connect consumers with farmers. The event was co-sponsored by Cornell Cooperative Extension.

Three-pronged approach is key to precision medicine

Combining genetic information from tumor cells with 3-D cell cultures grown from these tumors, and rapidly screening approved drugs, can identify the best treatment approaches in patients.

Veterinary College's new tests detect tick-borne diseases

A new process developed by Laura Goodman uses nanoscale technology that can detect multiple pathogens in ticks at once.

Food preservation team wins hospitality business contest

Five student teams competed for the chance to win $25,000 March 18 as part of Hotel Ezra Cornell's seventh annual Hospitality Business Plan Competition. This year's winner was Team Natural Cuts.

Weill Cornell Medicine celebrates Match Day 2017

Weill Cornell Medicine celebrated one of its best Match Days ever March 17, with 100 percent of the graduating medical students matching to residency positions - the next three to seven years of their medical careers.

Grant explores using seminal fluid proteins to control mosquitoes

Cornell researchers are exploring a new approach to reducing the spread of mosquito-borne viruses through seminal fluid proteins from male mosquitoes that disrupt the reproductive biology in females.

Delirium in critically ill children admitted to hospitals is common

One out of every four children admitted to intensive care units for critical illness develops delirium, according to an international study led by Weill Cornell Medicine investigators.

Gene mutation found to drive prostate cancer subtype

A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists.

Defense Department award funds prostate cancer study

Weill Cornell Medicine researchers will receive a grant from the Department of Defense to conduct a study of the molecular machinery driving the most aggressive prostate cancer.